Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2011-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2010.135871PMID 21216812PMCID PMC3058921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

  2012cited by this paper
• Statin Therapy in Rheumatoid Arthritis

  2012cited by this paper
• Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?

  2011cited by this paper
• Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins

  2010cited by this paper
• Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

  2010cited by this paper
• The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better

  2010cited by this paper
• Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure.

  2010cited by this paper
• Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience.

  2009cited by this paper
• Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence

  2009cited by this paper
• Contemporary treatment principles for early rheumatoid arthritis: a consensus statement.

  2009cited by this paper
• Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis

  2009cited by this paper
• Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Reverse Epidemiology in Systolic and Nonsystolic Heart Failure: Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors

  2009cited by this paper
• Which Measure of Inflammation to Use? A Comparison of Erythrocyte Sedimentation Rate and C-Reactive Protein Measurements from Randomized Clinical Trials of Golimumab in Rheumatoid Arthritis

  2009influential reference
• Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

  2009cited by this paper
• Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.

  2008cited by this paper
• Why do people with rheumatoid arthritis still die prematurely?

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit

  2007cited by this paper
• Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis

  2007cited by this paper
• CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Reverse Epidemiology beyond Dialysis Patients: Chronic Heart Failure, Geriatrics, Rheumatoid Arthritis, COPD, and AIDS

  2007cited by this paper
• Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis

  2007cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit

  2007cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

  2007cited by this paper
• Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study

  2006cited by this paper
• Patterns of cardiovascular risk in rheumatoid arthritis

  2006cited by this paper
• Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.

  2005cited by this paper
• Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

  2005cited by this paper
• C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan

  2005cited by this paper
• The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.

  2005cited by this paper
• Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.

  2004cited by this paper
• Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases.

  2004cited by this paper
• Cytokines and cytokine receptors

  2004cited by this paper
• Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

  2004cited by this paper
• Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.

  2003cited by this paper
• Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis

  2003cited by this paper
• The relationship between cholesterol and survival in patients with chronic heart failure.

  2003cited by this paper
• Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Modeling Survival Data: Extending the Cox Model

  2002cited by this paper
• Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study.

  2001cited by this paper
• Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST)

  2001cited by this paper
• Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity.

  2000cited by this paper
• Acute-phase proteins and other systemic responses to inflammation.

  1999cited by this paper
• Low Serum Cholesterol Levels Predict High Perioperative Mortality in Patients Supported by a Left-Ventricular Assist System

  1998cited by this paper
• Classification of heart failure in population based research: An assessment of six heart failure scores

  1997cited by this paper
• History of the Rochester Epidemiology Project.

  1996cited by this paper
• Low serum cholesterol and mortality. Which is the cause and which is the effect?

  1995cited by this paper
• By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

  1994cited by this paper
• The epidemiology of heart failure: the Framingham Study.

  1993cited by this paper
• Dyslipoproteinemia in the course of active rheumatoid arthritis.

  1992cited by this paper
• Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice.

  1990cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Generalized Additive Models

  1986cited by this paper
• The patient record in epidemiology.

  1981cited by this paper

• Association of lipid-based insulin resistance indices with rheumatoid arthritis prevalence: a cross-sectional study from NHANES 2007–2018

  2026cites this paper
• Short-Term Metabolic and Inflammatory Effects of Upadacitinib in Biologic-Refractory Spondyloarthritis: Real-World Evidence on Lipid Paradox and Safety.

  2026cites this paper
• Effects of DMARD and Anti-TNF Therapies on Inflammatory Markers, Lipid Profile, and Insulin Resistance in Rheumatoid Arthritis: A Controlled Study

  2026cites this paper
• Review of Literature Investigating the Correlation between Prevalence of Risk Factors Associated with Both Rheumatoid Arthritis and Cardiovascular Diseases

  2026cites this paper
• Pathogenic Drivers of Difficult-to-Treat Rheumatoid Arthritis: Synovium and Beyond.

  2026cites this paper
• Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid Arthritis.

  2026cites this paper
• Sex Differences in Atherosclerosis and its Clinical Complications

  2026cites this paper
• The prevalence of coronary artery disease in rheumatoid arthritis patients in Palestine: a cross-sectional study

  2026cites this paper
• Familial Mediterranean Fever and Long-Term Cardiovascular Disease Burden.

  2026cites this paper
• [Identification of high-risk preoperative blood indicators and baseline characteristics for multiple postoperative complications in rheumatoid arthritis patients undergoing total knee arthroplasty: a multi-machine learning feature contribution analysis].

  2025cites this paper
• Efficacy and safety of low-dose rosuvastatin/ezetimibe for dyslipidemia in patients with rheumatoid arthritis or osteoarthritis

  2025cites this paper
• Pathophysiological Links Between Inflammatory Bowel Disease and Cardiovascular Disease: The Role of Dysbiosis and Emerging Biomarkers

  2025cites this paper
• Investigation of Novel Therapeutic Targets for Rheumatoid Arthritis Through Human Plasma Proteome

  2025cites this paper
• CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS- A COMPREHENSIVE REVIEW OF MECHANISMS, ASSESSMENT, AND MANAGEMENT

  2025cites this paper
• Patient-Centric Approach for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease in Older People

  2025cites this paper
• Inflammation-Driven Lipid Suppression in Hospitalized Patients: Insights Into the Inflammatory Lipid Paradox From a Retrospective Study

  2025cites this paper
• Association between life’s essential 8 and risk of rheumatoid arthritis: a cross-sectional study

  2025cites this paper
• The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.

  2025cites this paper
• A study of lipid profile peculiarities and atherogenic index of plasma in patients younger than fifty years of age with newly diagnosed rheumatoid arthritis

  2025cites this paper
• Assessment of Carotid Stiffness and Strain Parameters Using Speckle Tracking Strain Ultrasonography in Rheumatoid Arthritis Patients

  2025cites this paper
• Acute Coronary Syndrome and Rheumatic Disease

  2025cites this paper
• Remnant Cholesterol Levels at Diagnosis May Predict Acute Coronary Syndrome Occurrence During Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

  2025cites this paper
• Unveiling the Lipid Paradox in Oral Leukoplakia: Metabolic Signatures of Dysplasia and Disease Progression

  2025cites this paper
• The association between cardiometabolic index and rheumatoid arthritis in American adults: the potential mediating role of hypertension, diabetes, and inflammatory markers

  2025cites this paper
• Dyslipidemia in Women with Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Beyond

  2025cites this paper
• The Effects of Disease-Modifying Antirheumatic Drugs on Cardiovascular Risk in Inflammatory Joint Diseases: Current Evidence and Uncertainties

  2025cites this paper
• The Role of Selected Myokines in the Development of Cardiovascular Diseases, and Their Involvement in Developing Heart Failure in Rheumatoid Arthritis Patients

  2025cites this paper
• Life's Essential 8 and Risk of All‐Cause and Cardiovascular Mortality in US Adults With Arthritis: A Retrospective Cohort Study Utilizing NHANES Database

  2025cites this paper
• Low-density lipoprotein cholesterol and clinical outcomes in patients with liver cirrhosis: a nationwide cohort study

  2025cites this paper
• Role of rheumatoid arthritis flare in the risk of Alzheimer’s disease and related dementias: a population-based cohort study

  2025influential citation
• Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial

  2025cites this paper
• Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster

  2025cites this paper
• Evaluating subclinical atherosclerosis, arterial stiffness, and lipid profile in patients with anti neutrophilic cytoplasmic antibodies associated vasculitis: a systematic review and meta-analysis

  2025cites this paper
• Circulating metabolic biomarkers predict incident sepsis: a large-scale population study in the UK Biobank

  2025cites this paper
• Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis—A Narrative Review

  2025cites this paper
• The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations

  2025cites this paper
• Cardiovascular disease risk factors in newly diagnosed rheumatoid arthritis: A retrospective cohort study.

  2025cites this paper
• Immunometabolism in cancer: a systemic perspective

  2025cites this paper
• Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritis

  2025cites this paper
• Metabolic and systemic inflammation status in rheumatoid arthritis—fasting blood glucose as a primary predictor of rheumatoid arthritis risk: a cross-sectional study in Iran

  2025cites this paper
• Impact of LDL-C levels on severity and outcome of intracranial haemorrhage: a single-centre retrospective study

  2025cites this paper
• Impact of Elevated Low-Density Lipoprotein and the Risk of Acute Coronary Syndrome in Rheumatoid Arthritis: A Retrospective Study

  2025cites this paper
• Developing an Interpretable Machine Learning Model for Early Prediction of Cardiovascular Involvement in Systemic Lupus Erythematosus

  2025cites this paper
• From Joints to the Heart: An Integrated Perspective on Systemic Inflammation

  2025cites this paper
• Modifications on lipid profile and high-density lipoprotein function related to treatment with tofacitinib in female patients with rheumatoid arthritis: Impact of previous therapy with biological agents.

  2025cites this paper
• Dysregulated serum lipid profile and atherosclerosis in untreated female Takayasu arteritis patients: a propensity score-matched analysis

  2025cites this paper
• Hyperlipidämie und Rheuma

  2025cites this paper
• Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases

  2024cites this paper
• Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary

  2024cites this paper
• Elevated remnant cholesterol as a potential predictor for cardiovascular events in rheumatoid arthritis patients

  2024cites this paper
• Estimation of Ten - Year Cardiovascular Disease Risk in Patients with Rheumatoid Arthritis using QRISK 3

  2024cites this paper
• Cardio-Rheumatology Insights Into Hypertension: Intersection of Inflammation, Arteries, and Heart

  2024cites this paper
• Lipid profile and mortality in patients with pulmonary thromboembolism; a systematic review and meta-analysis

  2024cites this paper
• Burden of Atherosclerotic Disease Risk Factors in patients with vs without Rheumatologic Disease: A Retrospective cohort study of US patients from the Houston Methodist Cardiovascular Disease Learning Health System Registry.

  2024cites this paper
• Incidence Rate of Cardiovascular Events in Rheumatoid Arthritis: An Observational Cohort Study in Saudi Arabia

  2024cites this paper
• Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients.

  2024cites this paper
• Dyslipidemia in cohorts of rheumatoid arthritis presented at Independent University Hospital Faisalabad.

  2024cites this paper
• Exploring the association of serum prolactin with serum glucose levels and clinical findings in a cohort of patients with early rheumatoid arthritis

  2024cites this paper
• Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia

  2024cites this paper
• Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge

  2024cites this paper
• Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial

  2024cites this paper
• Glycoprotein Acetyls Is a Novel Biomarker Predicting Cardiovascular Complications in Rheumatoid Arthritis

  2024cites this paper
• Lipoprotein(a) as a risk factor for cardiovascular diseases - focus on ischemic stroke (a position paper)

  2024cites this paper
• Guidelines of the Polish Society of Laboratory Diagnosticsand the Polish Lipid Association on laboratory diagnosticsof lipid metabolism disorders. 2024

  2024cites this paper
• Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis.

  2024cites this paper
• Association of ankylosing spondylitis with cardiovascular disease: a bidirectional two-sample mendelian randomization study

  2024cites this paper
• The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis

  2024cites this paper
• Evaluation of Naples prognostic score to predict long-term mortality in patients with pulmonary embolism.

  2024cites this paper
• Cardio-rheumatology: the cardiovascular, pharmacological, and surgical risks associated with rheumatological diseases in women

  2024cites this paper
• Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022.

  2024cites this paper
• Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review.

  2024cites this paper
• Cholesterin-Paradoxon: Herzrisiko trotz Norm-LDL bei rheumatoider Arthritis hoch

  2024cites this paper
• Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritis

  2024cites this paper
• Coronary Artery Disease in Women—Review of Risk Factors and Emerging Concepts

  2024cites this paper
• The management of cardiovascular risk in psoriatic disease: A bridge over troubled water.

  2024cites this paper
• Potential association of genetically predicted lipid and lipid-modifying drugs with rheumatoid arthritis: A Mendelian randomization study

  2024cites this paper
• Trends in Rheumatoid Arthritis associated Cardiovascular Mortality in the United States from 1999 to 2020.

  2024cites this paper
• Transsulfuration and folate pathways in rheumatoid arthritis: A systematic review and meta‐analysis

  2024cites this paper
• Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

  2024cites this paper
• Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease.

  2024cites this paper
• 2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders

  2024cites this paper
• Unraveling the Pleiotropic Role of High-Density Lipoproteins (HDLs) in Autoimmune Rheumatic Diseases

  2024cites this paper
• The potential impact of inflammation on the lipid paradox in patients with acute myocardial infarction: a multicenter study

  2024cites this paper
• High-density lipoprotein cholesterol subfraction HDL2 is associated with improved endothelial function in systemic lupus erythematosus

  2024cites this paper
• The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review

  2024cites this paper
• Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

  2024cites this paper
• Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women.

  2023cites this paper
• A serum metabolic biomarker panel for early rheumatoid arthritis

  2023cites this paper
• Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases

  2023cites this paper
• Role of Inflammatory Cytokines in Rheumatoid Arthritis and Development of Atherosclerosis: A Review

  2023cites this paper
• Elevated triglyceride levels are associated with increased risk for major adverse cardiovascular events in statin-naïve rheumatoid arthritis patients: A nationwide cohort study.

  2023cites this paper
• Increased Risk of Arterial Stiffness in Rhumatoid Arthritis Patients in a Sub-Saharan African Setting

  2023cites this paper
• Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib

  2023cites this paper
• Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis

  2023cites this paper
• Lipid metabolism and rheumatoid arthritis

  2023cites this paper
• The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients

  2023cites this paper
• Paradoxical Effects of Prolonged Insufficient Sleep on Lipid Profile: A Pooled Analysis of 2 Randomized Trials

  2023cites this paper
• Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus

  2023cites this paper
• The effect of HLA-DRB1*04:01 on a mouse model of atherosclerosis

  2023cites this paper
• Changes in the cholesterol profile of patients with rheumatoid arthritis treated with biologics or Janus kinase inhibitors

  2023cites this paper